651 related articles for article (PubMed ID: 26573127)
1. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
2. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Wagoner J; Keehn C; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population.
Askari SK; Schram SE; Wenner RA; Bowers S; Liu A; Bangerter AK; Warshaw EM
J Am Acad Dermatol; 2007 May; 56(5):739-47. PubMed ID: 17258839
[TBL] [Abstract][Full Text] [Related]
4. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
5. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms.
Rose CL; Chakravarti N; Curry JL; Torres-Cabala CA; Bassett R; Prieto VG; Tetzlaff MT
J Cutan Pathol; 2012 Aug; 39(8):762-8. PubMed ID: 22764884
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
Suiqing C; Min Z; Lirong C
J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
[TBL] [Abstract][Full Text] [Related]
7. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
8. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
9. Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation?
Flordelis JO; Shen YC; Wu YH
J Cutan Pathol; 2020 Mar; 47(3):207-218. PubMed ID: 31682281
[TBL] [Abstract][Full Text] [Related]
10. Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin.
Ramezani M; Mohamadzaheri E; Khazaei S; Najafi F; Vaisi-Raygani A; Rahbar M; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1379-83. PubMed ID: 27039776
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
12. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Expression of CD10 in Cutaneous Basal and Squamous Cell Carcinomas.
Aiad HA; Hanout HM
J Egypt Natl Canc Inst; 2007 Sep; 19(3):195-201. PubMed ID: 19190692
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD10 in basal cell carcinoma.
Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
[TBL] [Abstract][Full Text] [Related]
15. Microinvasive squamous cell carcinoma arising within seborrheic keratosis.
Terada T; Kamo M; Baba Y; Sugiura M
Cutis; 2012 Oct; 90(4):176-8. PubMed ID: 23259202
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry.
Richey JD; Deng AC; Dresser K; O'Donnell P; Cornejo KM
J Cutan Pathol; 2018 Aug; 45(8):603-609. PubMed ID: 29726030
[TBL] [Abstract][Full Text] [Related]
17. Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system.
Fremlin GA; Bray AP; de Berker DA
Clin Exp Dermatol; 2014 Aug; 39(6):689-95. PubMed ID: 25039592
[TBL] [Abstract][Full Text] [Related]
18. Value of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma.
Sari Aslani F; Akbarzadeh-Jahromi M; Jowkar F
Iran J Med Sci; 2013 Jun; 38(2):100-6. PubMed ID: 23825889
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression.
Servitje O; Climent F; Colomo L; Ruiz N; García-Herrera A; Gallardo F; Mercadal S; Pomares H; Muniesa C; Martin-Callizo C; Marcoval J; Rovira R; Estrach T; Pujol RM
J Cutan Pathol; 2019 Mar; 46(3):182-189. PubMed ID: 30511443
[TBL] [Abstract][Full Text] [Related]
20. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
Leblebici C; Bambul Sığırcı B; Kelten Talu C; Koca SB; Huq GE
Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
